TITLE:
Seasonal Affective Depression (SAD) Study

CONDITION:
Seasonal Affective Disorder (SAD)

INTERVENTION:
Extended-release Bupropion Hydrochloride

SUMMARY:

      A placebo controlled study evaluating the effectiveness of medication in preventing winter
      depressive episodes in patients with a history of Seasonal Affective Disorder
    

DETAILED DESCRIPTION:

      A 7-Month Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of
      150-300mg/day of Extended-release Bupropion Hydrochloride and Placebo for the Prevention of
      Seasonal Depressive Episodes in Subjects with a History of Seasonal Affective Disorder
      Followed by an 8-week Observational Follow-up Phase
    

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  History of Major Depressive Disorder (MDD) with a seasonal pattern.

        Exclusion Criteria:

          -  Current or past history of seizure disorder or brain injury.

          -  History or current diagnosis of anorexia nervosa or bulimia.

          -  Recurrent summer depression more frequently than winter depression.

          -  Primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD),
             Post-traumatic Stress Disorder(PTSD), acute distress disorder, bipolar II disorder or
             other psychotic disorders.

          -  Initiated psychotherapy within the last 3 months.
      
